Medpace Holdings IncMEDP
Price$598.08Intrinsic value$509.5215% below price

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
12.1%projected annual EPS growth
As of 27 Aug 2026
Analyst Coverage
12analysts covering
As of 18 Aug 2026
FY Revenue (est.)
$2.9Bnext fiscal year
As of 18 Aug 2026
FY EPS (est.)
$17.70next fiscal year
As of 18 Aug 2026
Monitoring Framework
Key Performance Indicators
Net Book-to-Bill Ratio Quarterly88.0%
Backlog Conversion Rate Quarterly2,330.0%
EBITDA Margin Quarterly2,110.0%
Watch Items
  • Backlog Cancellations
  • Biotech Funding Environment
Sign in / Sign up to read more

Research as of 2 Sep 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.